![](/img/cover-not-exists.png)
Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: Preliminary results of a case–control study
P. Pessaux, F. Panaro, S. Casnedi, I. Zeca, E. Marzano, P. Bachellier, D. Jaeck, M.P. ChenardVolume:
36
Year:
2010
Language:
english
Pages:
583
DOI:
10.1016/j.ejso.2010.04.010
File:
PDF, 145 KB
english, 2010